JP2006501133A5 - - Google Patents

Download PDF

Info

Publication number
JP2006501133A5
JP2006501133A5 JP2003550796A JP2003550796A JP2006501133A5 JP 2006501133 A5 JP2006501133 A5 JP 2006501133A5 JP 2003550796 A JP2003550796 A JP 2003550796A JP 2003550796 A JP2003550796 A JP 2003550796A JP 2006501133 A5 JP2006501133 A5 JP 2006501133A5
Authority
JP
Japan
Prior art keywords
use according
dysfunction
weight
hyaluronate
hyaluronic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003550796A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006501133A (ja
JP3994089B2 (ja
Filing date
Publication date
Priority claimed from DE10161110A external-priority patent/DE10161110A1/de
Application filed filed Critical
Publication of JP2006501133A publication Critical patent/JP2006501133A/ja
Publication of JP2006501133A5 publication Critical patent/JP2006501133A5/ja
Application granted granted Critical
Publication of JP3994089B2 publication Critical patent/JP3994089B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2003550796A 2001-12-12 2002-12-11 眼科学および鼻科学における適用のための薬学的組成物 Expired - Lifetime JP3994089B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10161110A DE10161110A1 (de) 2001-12-12 2001-12-12 Pharmazeutische Zusammensetzung zur ophthalmologischen und rhinologischen Anwendung
PCT/DE2002/004527 WO2003049747A1 (de) 2001-12-12 2002-12-11 Pharmazeutische zusammensetzung zur ophtalmologischen und rhinologischen anwendung

Publications (3)

Publication Number Publication Date
JP2006501133A JP2006501133A (ja) 2006-01-12
JP2006501133A5 true JP2006501133A5 (enExample) 2006-02-23
JP3994089B2 JP3994089B2 (ja) 2007-10-17

Family

ID=7708986

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003550796A Expired - Lifetime JP3994089B2 (ja) 2001-12-12 2002-12-11 眼科学および鼻科学における適用のための薬学的組成物

Country Status (11)

Country Link
US (1) US20050164979A1 (enExample)
EP (1) EP1455803B2 (enExample)
JP (1) JP3994089B2 (enExample)
CN (1) CN1310651C (enExample)
AT (1) ATE300306T1 (enExample)
AU (1) AU2002360895A1 (enExample)
CA (1) CA2468771C (enExample)
DE (2) DE10161110A1 (enExample)
ES (1) ES2244831T5 (enExample)
MX (1) MXPA04005387A (enExample)
WO (1) WO2003049747A1 (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10356248A1 (de) 2003-11-13 2005-06-23 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Pharmazeutische Zusammensetzung zur Behandlung von Rhinitiden
DE102004002001A1 (de) * 2004-01-14 2005-08-11 Reinmüller, Johannes, Dr.med. Mittel zur Behandlung von entzündlichen Erkrankungen
CN1285382C (zh) * 2004-12-20 2006-11-22 凌沛学 含海藻糖和玻璃酸的鼻腔用药传递系统及其制备方法
DE102005055275A1 (de) * 2005-11-17 2007-05-24 Ursapharm Arzneimittel Gmbh & Co. Kg Phosphatfreie pharmazeutische Zusammensetzung sowie deren Verwendung
WO2008011836A2 (es) 2006-07-25 2008-01-31 Osmotica Corp. Soluciones oftálmicas
WO2008068866A1 (en) * 2006-11-30 2008-06-12 Menicon Co., Ltd. Ophthalmic composition
KR100927579B1 (ko) * 2006-12-13 2009-11-23 주식회사 엘지생명과학 히아루론산 및/또는 그것의 염을 함유하는 아토피성피부염의 개선 및 치료를 위한 조성물
FR2919185B1 (fr) 2007-07-23 2010-09-10 Ard Sa Utilisation d'acide hyaluronique pour la preparation de compositions destinees a l'amelioration notamment de l'etat des muqueuses
DE202008016517U1 (de) * 2008-12-12 2009-03-05 Ratiopharm Gmbh Wässrige Zusammensetzung enthaltend Dexpanthenol und Natriumchlorid
US9473792B2 (en) 2009-11-06 2016-10-18 Texas Instruments Incorporated Method and system to improve the performance of a video encoder
FR2962044B1 (fr) * 2010-04-21 2013-02-22 Horus Pharma Emulsion lacrymimetique
CN103037858A (zh) * 2010-07-02 2013-04-10 华柏恩视觉研究中心 用于预防和治疗接触镜致乳头性结膜炎以及过敏性眼病的组合物
DE202010012255U1 (de) * 2010-09-07 2010-11-18 Krewel Meuselbach Gmbh Nasenspray
WO2012119261A1 (en) * 2011-03-10 2012-09-13 Biocia Inc. Enhanced artificial mucus composition comprising hyaluronan for the treatment of rhinitis
CN102579478A (zh) * 2012-03-30 2012-07-18 济南康众医药科技开发有限公司 玻璃酸钠在制备药物中的应用
DE202012005650U1 (de) * 2012-05-14 2013-05-15 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Kombinationstherapeutikum für die Behandlung von Rhinitis
EP2664330A1 (de) * 2012-05-15 2013-11-20 F. Holzer GmbH Zusammensetzung und Arzneimittel enthaltend Omega-3-Fettsäuren sowie einen Glucosaminoglucan
CN102989045B (zh) * 2012-11-12 2015-02-25 广州共禾医药科技有限公司 生物相容的水性组合物及其用途
BR112017002356A2 (pt) * 2014-08-08 2017-11-28 Shanghai Hightide Biopharmaceutical Ltd composições de formulação líquida, dispositivos de entrega de medicamento e métodos para preparação e uso dos mesmos
EP2985019B1 (en) 2014-08-16 2021-10-20 Church & Dwight Co., Inc. Nasal composition having anti-viral properties
EP2985027B1 (en) 2014-08-16 2021-03-31 Church & Dwight Co., Inc. Nasal composition comprising mixture of hyaluronic acids and saline solution
RS60926B1 (sr) 2015-03-26 2020-11-30 Dmg Italia Srl Oftalmološka kompozicija za zaštitu rožnjače
DE102016203696A1 (de) * 2016-03-07 2017-09-07 Ursapharm Arzneimittel Gmbh Ophthalmologische Zusammensetzung
DE102016204472A1 (de) * 2016-03-17 2017-09-21 Ursapharm Arzneimittel Gmbh Kit zur kosmetischen Behandlung des Auges und der Haut und Kosmetikum zur Anwendung am Auge und auf der Haut
TWI609957B (zh) 2016-06-27 2018-01-01 晶碩光學股份有限公司 用以處理隱形眼鏡之溶液及隱形眼鏡的包裝系統
JP7044467B2 (ja) * 2017-01-16 2022-03-30 ロート製薬株式会社 眼科組成物
DE102017117987A1 (de) * 2017-07-31 2019-01-31 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Neue Zusammensetzung für die nasale Applikation
CN107260657B (zh) * 2017-08-03 2019-02-05 广东莱恩医药研究院有限公司 一种缓释型连翘苷滴眼液及其制备方法
WO2019125330A2 (en) * 2017-08-10 2019-06-27 Eli̇xi̇r İlaç Araştirma Ve Geli̇şti̇rme A.Ş. Nasal decongestant compositions comprising dexpanthenol and sodium hyaluronate
US12303527B2 (en) 2018-04-18 2025-05-20 i.com medical GmbH High molecular weight hyaluronic acid for treatment and prevention of severe ocular surface disease
CA3097470A1 (en) * 2018-04-18 2019-10-24 i.com medical GmbH High molecular weight hyaluronic acid for enhancing epithelial survival and reconstitution of body surfaces
WO2020053783A1 (en) * 2018-09-12 2020-03-19 Neilos S.r.l. A composition for use in the prevention and/or treatment of epistaxis
US12268706B2 (en) 2019-01-31 2025-04-08 i.com medical GmbH Hyaluronic acid for relief of idiopathic ocular pain
EP3827818A1 (en) * 2019-11-26 2021-06-02 Warszawskie Zaklady Farmaceutyczne Polfa S.A. Ophthalmic composition
CN112870216A (zh) * 2021-01-29 2021-06-01 张宽才 一种药物组合物及制剂和用途
EP4039248B1 (en) * 2021-02-04 2026-01-28 Zaklady Farmaceutyczne Polpharma S.A. Ophthalmic composition
CN117771160A (zh) * 2022-09-22 2024-03-29 上海昊海生物科技股份有限公司 一种新型盐酸羟甲唑啉即型眼用凝胶及其制备方法
FR3151481A1 (fr) * 2023-07-28 2025-01-31 Horus Pharma Emulsion de type huile dans eau comprenant de l’acide hyaluronique et du dexpanthenol

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4851521A (en) * 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
JPS6479103A (en) * 1987-06-09 1989-03-24 Lion Corp External preparation
DE3832401A1 (de) † 1988-09-23 1990-03-29 Cassella Ag Pharmazeutische zubereitung zur behandlung entzuendeter nasenschleimhaeute
US5141741A (en) * 1988-12-09 1992-08-25 Lion Corporation Anti-sunburn skin-care preparation
IL101056A (en) † 1992-02-24 1997-03-18 Res & Dev Co Ltd Composition for nasal treatment
IT1273011B (it) * 1994-07-25 1997-07-01 Trhecnopharma S A Preparato oftalmico per l'uso come lacrima artificiale
DE19517251A1 (de) * 1995-05-11 1996-11-14 Klosterfrau Mcm Vetrieb Gmbh Verwendung von Dexpanthenol zur Behandlung trockener Nasenschleimhäute
DE19549421C2 (de) † 1995-11-10 1999-11-18 Klosterfrau Mcm Vetrieb Gmbh Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden
DE19541919C2 (de) † 1995-11-10 1997-11-20 Klosterfrau Mcm Vetrieb Gmbh Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden
CA2265767C (en) * 1997-07-11 2007-12-04 Nobuyuki Hanamura Stable pharmaceutical composition including 4,5-epoxy-morphinan derivative
DE19923829A1 (de) * 1999-05-17 2000-11-23 Ulrich Kluegel Hyaluronat-Wirkstoff-Wasser-Komplex, dessen Herstellung und Verwendung
RU2333742C2 (ru) * 2001-01-09 2008-09-20 Луи Йохан ВАГЕНАР Применение декспантенола в композиции для ухода за контактными линзами

Similar Documents

Publication Publication Date Title
JP3994089B2 (ja) 眼科学および鼻科学における適用のための薬学的組成物
JP2005513106A5 (enExample)
CN102695497B (zh) 可注射的含水眼用组合物及其应用方法
JP6527468B2 (ja) ヒアルロン酸ナトリウムとカルボキシメチルセルロースを含む人工涙液
JP5841151B2 (ja) 鼻腔噴霧剤
JP2022008403A5 (enExample)
JP2015025011A5 (enExample)
RU2013125021A (ru) Местные композиции для сохранения или восстановления целостности слизистых оболочек
JP2007500244A5 (enExample)
ES2259727T3 (es) Agente oftalmico que contiene heparina.
JP2011037891A5 (enExample)
ATE511847T1 (de) Pharmazeutische zubereitung für die behandlung entzündlicher erkrankungen des urogenitaltraktes
WO2007108541A1 (ja) キサンタンガムおよびブドウ糖を含有する眼科用組成物
SI2760821T1 (en) A salt salt of an anti-inflammatory substituted cyclobutenedione compound
JP2006512324A5 (enExample)
RU2015128496A (ru) Лечение аллергического ринита с использованием комбинации мометазона и олопатадина
ATE529417T1 (de) 3',4',5-trimethoxyflavonderivate als die schleimsekretion stimulierendes mittel, entsprechendes verfahren und pharmazeutische zusammensetzung, die diese enthält
ES2336668T3 (es) Composicion farmaceutica para el tratamiento de rinitis.
JP6842794B2 (ja) 皮膚外用製剤
JP2016535094A5 (enExample)
HRP20191144T1 (hr) Sirnk i njihova primjena u metodama i spojevima za liječenje i/ili prevenciju stanja oka
ES2719898T3 (es) Composiciones orales para el tratamiento de la enfermedad de reflujo gastroesofágico
JP2007517885A5 (enExample)
FI3706710T3 (fi) Pitkäkestoisesti vapautuvia formulaatioita nivelensisäisiin käyttötarkoituksiin
RU2018125252A (ru) Синергическая комбинация пирролидонкарбоновой кислоты и/или ее солей и гиалуроновой кислоты и/или ее солей для применения в лечении и/или профилактике сухости и раздражения слизистых оболочек, и связанные фармацевтические композиции